Concepedia

Liangwei Wu

LW

Statistics

Publications

2

Citations

129

H-Index

2

Active since

2020

Affiliations

AstraZeneca (United Kingdom)(Current)

AstraZeneca (United States)

Liangwei Wu is an author at AstraZeneca (United Kingdom) specializing in target engagement optimization, drug-target engagement, and cancer pharmacology.

Publications per year

2020–2021

2

Publications

2

Discovery of AZD4573, a Potent and Selective Inhibitor of CDK9 That Enables Short Duration of Target Engagement for the Treatment of Hematological Malignancies

Bernard Barlaam, Robert Casella, Justin Cidado et al. · Journal of Medicinal Chemistry · 2020 · 104 citations · Full text

, , +15

Discovery of a Series of 7-Azaindoles as Potent and Highly Selective CDK9 Inhibitors for Transient Target Engagement

Bernard Barlaam, Chris De Savi, Allan Dishington et al. · Journal of Medicinal Chemistry · 2021 · 25 citations · Full text

, , +16

1–2 of 2